CIK 0001671858 · Non-accelerated filer<br>Smaller reporting company
ARS Pharmaceuticals, Inc.
Sign in to watch- Ticker
- SPRY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811489190
- Phone
- 858-771-9307
- Business address
- 11682 EL CAMINO REAL, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Silverback Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-07-16 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −50,000 | $11.40 | $570K | 1,598,499 |
| 2024-07-16 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale 10b5-1 | −50,000 | $11.40 | $570K | 1,547,447 |
| 2024-07-16 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale 10b5-1 | −50,000 | $11.40 | $570K | 1,598,499 |
| 2024-07-09 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale 10b5-1 | −50,000 | $9.62 | $481K | 1,496,494 |
| 2024-07-09 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale 10b5-1 | −50,000 | $9.62 | $481K | 1,648,499 |
| 2024-07-09 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −50,000 | $9.62 | $481K | 1,496,494 |
| 2024-07-09 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −50,000 | $9.62 | $481K | 1,648,499 |
Page 14 of 14 · 267 trades